ClinicalTrials.Veeva

Menu

Post Operative Shivering Following Anesthesia

S

Sohag University

Status

Not yet enrolling

Conditions

Shivering, Spinal Anesthesia

Treatments

Drug: Mg (magnesium sulfate)
Drug: Ondansetron 8 mg
Drug: Dexmedetomidin

Study type

Interventional

Funder types

Other

Identifiers

NCT07377903
Soh_med__25_12_10MS

Details and patient eligibility

About

The aim of this study is to compare the efficacy of magnesium sulphate, ondansetron, and dexmedetomidine in managing post-spinal anesthesia shivering. The primary aim is the time to cessation of shivering after drug administration, while secondary aim include hemodynamic parameters (heart rate, blood pressure, SpO₂ ) and the recurrence of shivering

Full description

This is a randomized double blinded study including patients undergoing surgery under spinal anesthesia. Patients will be randomly allocated into three groups to receive magnesium sulphate, ondansetron, or dexmedetomidine for the treatment of post-spinal anesthesia shivering. The time to cessation of shivering, hemodynamic parameters, and recurrence of shivering will be recorded.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age from 18 to 45 years.
  • Both sexes.
  • American Society of Anesthesiologists physical status I, II
  • Scheduled for elective lower abdominal or lower limb surgeries under spinal anesthesia

Exclusion criteria

  • Patients with known allergy to study drugs.
  • Patients with baseline body temperature outside the normal range (36-37.5°C).
  • History of thermoregulatory disorders, thyroid dysfunction, or neurological diseases.
  • Patients receive sedatives, antipsychotics, or antidepressants.
  • Patients require intraoperative conversion to general anesthesia.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 3 patient groups

Mg sulphate group
Experimental group
Description:
50 mg/kg magnesium sulphate diluted in 100 mL of normal saline.
Treatment:
Drug: Mg (magnesium sulfate)
dexmedetomidine group
Experimental group
Treatment:
Drug: Dexmedetomidin
ondansetron group
Experimental group
Treatment:
Drug: Ondansetron 8 mg

Trial contacts and locations

0

Loading...

Central trial contact

Ahmed Elsaied Abd Elrahman, Professor; Aya Mohammed Aboelwafa, Resident of anesthesia

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems